AU4756697A - Use of 8,9-dehydroestrone for the manufacture of a medicament for the treatment of vasomotor symptoms - Google Patents

Use of 8,9-dehydroestrone for the manufacture of a medicament for the treatment of vasomotor symptoms

Info

Publication number
AU4756697A
AU4756697A AU47566/97A AU4756697A AU4756697A AU 4756697 A AU4756697 A AU 4756697A AU 47566/97 A AU47566/97 A AU 47566/97A AU 4756697 A AU4756697 A AU 4756697A AU 4756697 A AU4756697 A AU 4756697A
Authority
AU
Australia
Prior art keywords
dehydroestrone
medicament
manufacture
treatment
vasomotor symptoms
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU47566/97A
Inventor
Cecil Richard Lyttle
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wyeth LLC
Original Assignee
American Home Products Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Home Products Corp filed Critical American Home Products Corp
Publication of AU4756697A publication Critical patent/AU4756697A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/566—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol having an oxo group in position 17, e.g. estrone

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU47566/97A 1996-10-16 1997-10-15 Use of 8,9-dehydroestrone for the manufacture of a medicament for the treatment of vasomotor symptoms Abandoned AU4756697A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US73305196A 1996-10-16 1996-10-16
US08733051 1996-10-16
PCT/US1997/018545 WO1998016232A1 (en) 1996-10-16 1997-10-15 Use of 8,9-dehydroestrone for the manufacture of a medicament for the treatment of vasomotor symptoms

Publications (1)

Publication Number Publication Date
AU4756697A true AU4756697A (en) 1998-05-11

Family

ID=24946027

Family Applications (1)

Application Number Title Priority Date Filing Date
AU47566/97A Abandoned AU4756697A (en) 1996-10-16 1997-10-15 Use of 8,9-dehydroestrone for the manufacture of a medicament for the treatment of vasomotor symptoms

Country Status (4)

Country Link
AR (1) AR008675A1 (en)
AU (1) AU4756697A (en)
WO (1) WO1998016232A1 (en)
ZA (1) ZA979204B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2481310A1 (en) * 2002-04-03 2003-10-16 Barr Laboratories, Inc. Step-down estrogen therapy

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5210081A (en) * 1992-02-26 1993-05-11 American Home Products Corporation Alkali metal 8,9-dehydroestrone sulfate esters

Also Published As

Publication number Publication date
AR008675A1 (en) 2000-02-09
ZA979204B (en) 1999-04-14
WO1998016232A1 (en) 1998-04-23

Similar Documents

Publication Publication Date Title
AU6914894A (en) Process for the manufacture of 1,1,1,2,3-pentafluoropropane
AU2805195A (en) Therapeutic compounds
NZ297342A (en) Thiadiazolidin-3-one 1,1-dioxides; medicaments
ZA9710322B (en) Process for the preparation of benzyl-ethers.
AU5801996A (en) Use of 1,2,4-triazole derivatives for the manufacture of a medicament for the treatment of cancers
AU2523795A (en) Inhaler
AU4278897A (en) 10,13,15-Trioxatricyclo(9.2.1.1.9.6)-Pentadecanone derivatives, method for the production thereof and medicaments containing these compounds
AU1116895A (en) Use of theophylline for the manufacture of a medicament for the treatment of asthma
ZA986885B (en) A process for the preparation of cyclopropylacetylene.
AU4174196A (en) Process for the preparation of a pharmacologically active chemical combination
AUPM456894A0 (en) Treatment for gastric disorders
ZA97872B (en) Use of pyrolidine derivatives for the manufacture of medicaments.
AU4729396A (en) Process for the preparation of 1,2-benzisothiazolin-3-ones
EP0694538A3 (en) 2-benzyloxy-4-phenoxypyrimidine derivative, processes for producing the derivative and herbicidal composition containing the derivative
AU7845098A (en) Pharmaceutical compositions comprising a 4-arylcoumarin for the treatment f vir al infections
AU4756697A (en) Use of 8,9-dehydroestrone for the manufacture of a medicament for the treatment of vasomotor symptoms
AU7726796A (en) Use of 3-oxa-d-prostaglandins for the manufacture of a medicament for the treatment of glaucoma
AU4217897A (en) Use of ozone for the manufacture of gaseous medicaments
HUP0001751A3 (en) A process for the preparation of 1,4,7,10-tetraazacyclododecane
AU3071899A (en) Use of pkc-inhibitors for the manufacture of a medicament for the treatment of asthma
HK1010095A1 (en) Use of 8,9-dehydroestrone for the manufacture of amedicament for the treatment of diseases caused byfree radicals.
AU2387597A (en) Process for the hydroxylation of 1,4-dichlorobenzene
AU5982199A (en) Process for the preparation of 4,4'-dihalogen-o-hydroxydiphenyl compounds
AU3877795A (en) Toxins from the wasp bracon hebetor
AU3765897A (en) Use of a plasminogen activator for the treatment of pulmonary disorders